Free Trial

Tarsus Pharmaceuticals (TARS) Insider Trading & Ownership

Tarsus Pharmaceuticals logo
$61.21 -2.75 (-4.30%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$61.16 -0.05 (-0.07%)
As of 05/8/2026 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.97%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$8.70M
Get TARS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tarsus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TARS Insider Buying and Selling by Quarter

Tarsus Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/19/2026Sell11,964$67.00$801,588.00  
3/19/2026
Bryan Wahl
Bryan Wahl
General Counsel
Sell4,231$67.00$283,477.00  
3/19/2026Sell4,174$67.00$279,658.00  
3/19/2026Sell390$67.00$26,130.00  
3/19/2026
Jeffrey S Farrow
Insider
Sell2,186$67.00$146,462.00  
3/18/2026Sell11,667$68.71$801,639.57  
3/18/2026
Bryan Wahl
Bryan Wahl
General Counsel
Sell4,125$68.71$283,428.75  
3/18/2026Sell4,071$68.71$279,718.41  
3/18/2026Sell379$68.71$26,041.09  
3/18/2026
Jeffrey S Farrow
Insider
Sell2,133$68.71$146,558.43  
3/17/2026Sell10,972$69.42$761,676.24  
3/17/2026
Bryan Wahl
Bryan Wahl
General Counsel
Sell4,084$69.42$283,511.28  
3/17/2026Sell4,029$69.42$279,693.18  
3/17/2026Sell375$69.42$26,032.50  
3/17/2026
Jeffrey S Farrow
Insider
Sell2,111$69.42$146,545.62  
3/16/2026Sell12,500$68.79$859,875.00  
12/24/2025Sell6,000$82.51$495,060.00  
12/16/2025Sell7,397$80.10$592,499.70  
9/24/2025Sell6,000$55.37$332,220.00  
9/8/2025Sell27,116$57.00$1,545,612.00  
8/11/2025Sell6,000$50.00$300,000.00  
(Data available from 1/1/2013 forward)

TARS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Tarsus Pharmaceuticals includes Andrew D Goldberg, Aziz Mottiwala, Bobak R Azamian, Bryan Wahl, Dianne C Whitfield, Elizabeth Yeu Lin, Jeffrey S Farrow, Jose M Trevejo, Seshadri Neervannan, and William J Phd Link. Learn more on insiders at TARS.

8.97% of Tarsus Pharmaceuticals stock is owned by insiders. Learn more on TARS's insider holdings.

The following insiders have sold TARS shares in the last 24 months: Bobak R Azamian ($4,549,916.54), Bryan Wahl ($1,159,611.16), Dianne C Whitfield ($1,645,815.71), Elizabeth Yeu Lin ($78,203.59), Jeffrey S Farrow ($439,566.05), and William J Phd Link ($2,405,487.00).

Insiders have sold a total of 164,446 Tarsus Pharmaceuticals shares in the last 24 months for a total of $10,278,600.05 sold.



This page (NASDAQ:TARS) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners